• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Lucira Health Inc (NQ: LHDX )

    N/A UNCHANGED
    Last Price Updated: 4:00 PM EST, Mar 3, 2023 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Lucira Health Inc

    Lucira Health Announces U.S. Launch of First & Only At-Home Combination COVID-19 & Flu Test Amidst Sale Process
    Combination Test Also Secures Point-Of-Care Authorization in Australia 
    From Lucira Health Inc.
    Via GlobeNewswire
    Lucira Stock Jumps over 250% on FDA Approval, Beware Chapter 11
    Lucira Health Inc. (NASDAQ: LHDX) shares spiked up 264% to close at $0.52 on a massive 278 million shares traded on the announcement of FDA approval for its 
    Via MarketBeat
    Topics Initial Public Offering
    Exposures COVID-19 Product Safety Securities Market
    Lucira Health Announces FDA Authorization of First & Only At-Home Combination Covid-19 & Flu Test and Comments on Chapter 11 Bankruptcy Filing
    Test Delivers Lab-Quality Performance with Results in 30 Minutes or Less – The First At-Home Test to Ever Include Flu 
    From Lucira Health Inc.
    Via GlobeNewswire
    Lucira Health to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process
    No debtor-in-possession financing required as the Company intends to fund operations and the sale process with available cash on hand. 
    From Lucira Health Inc.
    Via GlobeNewswire
    Lucira Health Launches Lucira Connect, a Free Test-to-Treat Telehealth Service for Covid-19 or Flu in Canada
    From Lucira Health Inc.
    Via GlobeNewswire
    Lucira Health Submits EUA for Over-The-Counter (OTC) Use of its COVID-19 & Flu Test
    From Lucira Health Inc.
    Via GlobeNewswire
    Lucira Health Announces FDA Authorization of Combination COVID-19 & Flu Test at Point-of-Care
    PCR-Quality Accuracy with Results in 30 Minutes or Less, Just in Time for Flu Season 
    From Lucira Health Inc.
    Via GlobeNewswire
    Lucira Health Announces National Launch of Lucira Connect Test-to-Treat Service
    From Lucira Health Inc.
    Via GlobeNewswire
    Lucira Health Announces Third Quarter 2022 Results and Provides Business Updates
    From Lucira Health Inc.
    Via GlobeNewswire
    Lucira Health to Announce Third Quarter 2022 Financial Results
    From Lucira Health Inc.
    Via GlobeNewswire
    Lucira Health Reports Pilot Study Interim Results for Chlamydia and Gonorrhea Assays
    Study Reveals Lucira’s Testing Assays Offer a 98% Accuracy Rate in Detecting Both Sexually Transmitted Infections 
    From Lucira Health Inc.
    Via GlobeNewswire
    INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Lucira Health, Inc. and Encourages Investors with Losses to Contact the Firm
    LOS ANGELES, CA - (NewMediaWire) - December 5, 2021 - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Lucira... 
    Via NewMediaWire
    Topics Lawsuit
    Exposures COVID-19 Financial Legal
    INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Lucira Health, Inc. and Encourages Investors with Losses to Contact the Firm
    From The Schall Law Firm
    Via Business Wire
    INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Lucira Health, Inc. and Encourages Investors with Losses to Contact the Firm
    From The Schall Law Firm
    Via Business Wire
    LHDX EQUITY ALERT: Rosen Law Firm Encourages Lucira Health, Inc. Investors with Losses to Inquire About Class Action Investigation – LHDX
    From The Rosen Law Firm, P.A.
    Via Business Wire
    LUCIRA™ HEALTH Hires Ghazi Kashmolah as Chief Quality Officer and EVP Regulatory Affairs
    From Lucira Health, Inc.
    Via Business Wire
    LUCIRA™ HEALTH Hires Chief Revenue Officer Kevin Collins
    From Lucira Health, Inc.
    Via Business Wire
    LUCIRA™ CHECK IT COVID-19 Self-Test Now Available on Amazon
    From Lucira Health, Inc.
    Via Business Wire
    Lucira Health Celebrates Grand Opening of New Jabil Manufacturing Plant, Increasing Production of LUCIRA CHECK IT™ COVID-19 Self-Test
    From Lucira Health, Inc.
    Via Business Wire
    Health Canada Authorizes First COVID-19 Test For Self-Testing At Home
    From Lucira Health, Inc.
    Via Business Wire
    For the First Time Ever, NBA Fans Can Test Themselves for COVID-19 Before Attending a Live Game. Testing Program Debuts in San Francisco Bay Area this Friday with LUCIRA™ Check It COVID-19 At-Home Test
    From Lucira Health, Inc.
    Via Business Wire
    FDA Authorizes First Single-Use, PCR Quality Over the Counter (OTC) LUCIRA CHECK IT™ COVID-19 At-Home Test. Available Now.
    From Lucira Health, Inc.
    Via Business Wire
    LUCIRA COVID-19 Test Kit Identifies Viral Variants
    From Lucira Health, Inc.
    Via Business Wire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.